Doxorubicin and paclitaxel co-bound lactosylated albumin nanoparticles having targetability to hepatocellular carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Doxorubicin and paclitaxel co-bound lactosylated albumin nanoparticles having targetability to hepatocellular carcinoma

Published:2017-04 Issue: Volume:152 Page:183-191
ISSN:0927-7765
Container-title:Colloids and Surfaces B: Biointerfaces
language:en
Short-container-title:Colloids and Surfaces B: Biointerfaces

Author:

Thao Le Quang,Lee Changkyu,Kim Bomi,Lee Sungin,Kim Tae Hwan,Kim Jong Oh,Lee Eun Seong,Oh Kyung Taek,Choi Han-Gon,Yoo Sun Dong,Youn Yu Seok

Funder

Ministry of Food and Drug Safety

Publisher

Elsevier BV

Subject

Colloid and Surface Chemistry,Physical and Theoretical Chemistry,Surfaces and Interfaces,General Medicine,Biotechnology

Reference36 articles.

1. Glycyrrhetinic acid mediated drug delivery carriers for hepatocellular carcinoma therapy;Cai;Mol. Pharmaceut.,2016

2. The strategies for treating primary hepatocellular carcinoma with portal vein tumor thrombus;Zhang;Int. J. Surg.,2015

3. Hepatocellular carcinoma: will novel targeted drugs really impact the next future?;Montella;World J. Gastroenterol.,2016

4. Global cancer statistics;Jemal;Ca-Cancer J. Clin.,2011

5. Hepatocellular carcinoma: epidemiology and clinical aspects;Mazzanti;Mol. Asp. Med.,2008

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interactions of human serum albumin with phosphate and Tris buffers: impact on paclitaxel binding and nanoparticles self-assembly;Journal of Microencapsulation;2024-09-13

2. Glycosylated nanoplatforms: From glycosylation strategies to implications and opportunities for cancer theranostics;Journal of Controlled Release;2024-07

3. Silk Nanofiber Carriers for Both Hydrophilic and Hydrophobic Drugs to Achieve Improved Combination Chemotherapy;Macromolecular Bioscience;2024-02-07

4. Recent advances of novel targeted drug delivery systems based on natural medicine monomers against hepatocellular carcinoma;Heliyon;2024-01

5. Gemcitabine Loaded Galactosylated Albumin Nanoparticles for the Effective Treatment of Hepatocellular Carcinoma;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3